A growing, but poorly defined subset of patients with chronic limb-threatening ischemia (CLTI) have "no option" for revascularization. One notable subgroup includes patients with severe ischemia and advanced pedal artery occlusive disease, termed "desert foot," who are at high risk for major amputation due to a lack of conventional revascularization options. Although new therapies are being developed for no-option patients with desert foot anatomy, this subgroup and the broader group of no-option patients are not well defined, limiting the ability to evaluate outcomes. Based on a systematic review, a classification of the no-option CLTI patient was constructed for use in clinical practice and studies. Several no-option conditions were identified, including type I-severe and pedal occlusive disease (desert foot anatomy) for which there is no accepted method of repair; type II-lack of suitable venous conduit for bypass in the setting of an acceptable target for bypass; type III-extensive tissue loss with exposure of vital structures that renders salvage impossible; type IV-advanced medical comorbidities for which available revascularization options would pose a prohibitive risk; and type V-presence of a nonfunctional limb. While type I and type II patients may have no option for revascularization, type III and type V patients have wounds, infection, comorbidities, or functional status that may leave them with few options for revascularization. As treatment strategies continue to evolve and novel methods of revascularization are developed, the ability to identify no-option patients in a standardized fashion will aid in treatment selection and assessment of outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1526602820963911DOI Listing

Publication Analysis

Top Keywords

no-option patients
12
type
9
chronic limb-threatening
8
limb-threatening ischemia
8
occlusive disease
8
revascularization options
8
desert foot
8
foot anatomy
8
type patients
8
patients
7

Similar Publications

Background: Chronic limb-threatening ischemia (CLTI) leads to decreased quality of life and increased disease burden, resulting in progressive patient deterioration, limb amputation, and mortality.

Objectives: This study aims to present the outcomes of a Latin American experience using the open distal venous arterialization (DVA) technique for no-option limb salvage in a high volume CLTI center.

Methods: A retrospective case series study was performed including patients from 2018 to 2022 using a population from Bogotá, Colombia.

View Article and Find Full Text PDF

Chronic limb-threatening ischemia (CLTI), the most advanced form of peripheral arterial disease (PAD), is the comorbidity primarily responsible for major lower-limb amputations, particularly for diabetic patients. Autologous cell therapy has been the focus of efforts over the past 20 years to create non-interventional therapeutic options for no-option CLTI to improve limb perfusion and wound healing. Among the different available techniques, peripheral blood mononuclear cells (PBMNC) appear to be the most promising autologous cell therapy due to physio-pathological considerations and clinical evidence, which will be discussed in this review.

View Article and Find Full Text PDF
Article Synopsis
  • Breast cancer-related lymphedema (BCRL) affects about 1 in 3 survivors, with current treatments not addressing the root cause; studies suggest adipose-derived regenerative cells (ADRCs) and lipotransfer might help.
  • A randomized, double-blind trial involved 80 patients with persistent BCRL, comparing ADRCs and lipotransfer against a placebo to measure changes in lymphedema volume and quality of life after one year.
  • Results showed no objective differences between treatment and placebo groups, although both reported subjective improvements; the study concludes that ADRC and lipotransfer are not beneficial for BCRL, but suggests further research might be needed with different dosages or repeated treatments.
View Article and Find Full Text PDF

Total avulsion of the scalp represents a therapeutic challenge with no consensus nowadays. Currently, microsurgical reimplantation is the reconstructive procedure of choice, but in case it is not feasible, the literature does not define an ideal treatment for an immediate reconstruction. We present the case of an 18-year-old woman with total avulsion of the scalp and forehead skin without possibility of reimplantation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!